---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-076868"
form_type: "8-K"
ticker: "LQDA"
cik: "0001819576"
company_name: "Liquidia Corp"
filed_at: "2022-07-01T23:59:59+00:00"
generated_at: "2026-06-24T21:46:08.189635+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Liquidia enters severance agreement with departing CMO Tushar Shah

## Summary
- Dr. Tushar Shah's employment as Chief Medical Officer terminated effective June 15, 2022.
- Severance provides 9 months base salary in equal installments and COBRA premium payments.
- Shah signed general release of claims and agreed to non-disparagement and confidentiality.

## SEC filing metadata
- accession: 0001104659-22-076868
- form_type: 8-K
- ticker: LQDA
- cik: 0001819576
- company_name: Liquidia Corp
- filed_at: 2022-07-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819576/000110465922076868/0001104659-22-076868-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819576/000110465922076868/tm2220218d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-076868
- JSON: https://secwatch.observer/filing/0001104659-22-076868.json
- Plain text: https://secwatch.observer/filing/0001104659-22-076868.txt

## Key facts
- Executive change
  Tushar Shah was terminated as Chief Medical Officer at Liquidia Corp.
  - Action: terminated
  - Role: Chief Medical Officer
  source text: As previously disclosed, effective June 15, 2022 (the “Separation Date”), Tushar Shah, M.D.’s employment with Liquidia Corporation, a Delaware corporation (the “Company”) as the Company’s Chief Medical Officer terminated.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819576/000110465922076868/0001104659-22-076868-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.